SCHEMBL14701704

SCHEMBL14701704

N/C(C=O)=N\Nc1ccc(F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 1/20 0.42
KCNH2 Q12809 1/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA4 P22748 1/20 0.41
CA7 P43166 1/20 0.41
MEN1 O00255 6/20 0.40
KMT2A Q03164 6/20 0.40
MAPT P10636 2/20 0.40
ALOX12 P18054 2/20 0.40
AHR P35869 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
IDO1 P14902 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
HTT P42858 1/20 0.39
F2 P00734 1/20 0.39
PRSS1 P07477 1/20 0.39
PRSS2 P07478 1/20 0.39
PRSS3 P35030 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2284972 0.78 ALDH1A1 (0.50) ALDH1A1KDM4ECA1CA2CA4
SCHEMBL2284980 0.78 ALDH1A1 (0.50) ALDH1A1KDM4ECA1CA2CA4
SCHEMBL2284982 0.78 ALDH1A1 (0.50) ALDH1A1KDM4ECA1CA2CA4
SCHEMBL24253615 0.73 CA1 (0.47) ALDH1A1KDM4ECA1CA2CA4
SCHEMBL21777219 0.73 KMT2A (0.41) ALDH1A1KDM4ECA1CA2CA4
SCHEMBL12815704 0.72 ALDH1A1 (0.44) ALDH1A1KDM4EKCNH2CA1CA2
SCHEMBL15939608 0.70 ALDH1A1 (0.49) ALDH1A1KDM4ECA1CA2CA4
SCHEMBL18463191 0.70 ALDH1A1 (0.58) ALDH1A1KDM4ECA1CA2CA4
SCHEMBL518754 0.68 ALDH1A1 (0.51) ALDH1A1KDM4ECA1CA2CA4
SCHEMBL12443593 0.68 MEN1 (0.53) ALDH1A1KDM4EKCNH2CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9284350-B2 IAP BIR domain binding compounds PHARMASCIENCE INC. (CA) 2016-03-15 US disclosed
US-20130040892-A1 IAP BIR DOMAIN BINDING COMPOUNDS PHARMASCIENCE INC. (CA) 2013-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130040892-A1 IAP BIR DOMAIN BINDING COMPOUNDS BIRC5, BIRC2, BIRC3 ALDH1A1 4122/4885KDM4E 3728/4885KCNH2 4012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.